Delve Bio | Biotech/Pharma | Standout | Standout

Delve Bio

43 employees

Biotech/Pharma

Series A · $35.0M

Open positions (1)

Clinical Account Executive

Remote

Company details

Team Size43

IndustryBiotech/Pharma

Funding

Total raised

$35.0M

Last stage

Series A

Investors

Perceptive Xontogeny Venture Fund II

Section 32

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Earn $3,000

ProductHow it works For talent For companies Browse jobs Browse companies

CompanyAbout Blog Careers

ConnectTwitter / X LinkedIn

Standout.

Privacy Terms

Founders

Charles Chiu

Co-founder of Delve Bio and professor at UCSF. World leader in genomics and metagenomics for infectious disease. Author of 200+ peer-reviewed publications, holds 15+ patents. Also serves on the scientific advisory boards of Mammoth Biosciences and others.

Matthew Meyerson

Co-founder of Delve Bio. World leader in genomics affiliated with Harvard Medical School and the Broad Institute of MIT and Harvard.

Bradley Murray

Co-founder and CEO of Delve Bio. Previously a senior associate at Xontogeny making seed and Series A investments in life sciences. Earlier was a computational biologist at Intellia Therapeutics and a computational associate at The Broad Institute. Holds a BS from Georgetown University and an MBA from Boston College.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.